The Northwest Center
for Environmental Medicine
Comprehensive Allergy Evaluation and Treatment
Noninvasive Cardiovascular Disease Intervention
Individual, Family and Group Counseling
Click the button below to learn more about EECP.
MCS Treatments
Treating patients with MCS is very challenging because of the ubiquitous level of toxic chemicals present throughout our modern-day environment. There is no completely satisfactory treatment of patients with this condition. Avoidance of the offending chemicals is the only thing that consistently works. For some, moderately reducing the level of exposures is all they need to do. This may simply involve making their bedroom environmentally safe, whereas for others it might require making the entire house into a chemically free haven.
Others have nutritional deficits that cause them to be more susceptible to the effects of toxic chemicals. This would include inadequate antioxidant protection and/or metabolic abnormalities and amino acid deficiencies that are important in maintaining our detoxification systems. These deficits can be identified to lab tests and be corrected.
Some patients have been adversely affected by chronic viral or fungal infections that can be treated. Another group of patients had accumulated high levels of various toxic chemicals, including pesticides and solvents. These patients can often markedly improve by going through through an environmental detoxification program, to "de-pollute" their body. This might involve special detoxification nutritional formulas and/or sauna depuration.
Other treatments that have been shown to be helpful for chemical hypersensitivity include the following:
- Neural Sensitization Protocol
- Nasal Procaine
- Nasal and/or Nebulized Glutathione
- Intravenous Glutathione
- Intravenous Vitamin C
- Nasal Vitamin B 12
- Dextromethorphan
- Sodium Sulfate
External Enhanced Counterpulsation (EECP) is a novel and relatively new approach to treating patients with MCS and those with toxic affects of chemicals and mycotoxins. Many patients with these conditions have sustained toxic affects on their vascular system-a toxic vasculitis. This condition results in compromised microvascular function, which leads to reduced delivery of oxygen and nutrients to cells, accumulation of metabolic waste products, metabolic acidosis, impaired detoxification and general dysfunction of organ systems such as the liver and brain. EECP can markedly improve vascular function, deliver oxygen and nutrients to cells and safely detoxify the body.
EndoPat testing can establish whether or not EECP would be helpful in specific conditions, although it is not a requirement before EECP treatments are undertaken.
These treatments work for some patients and not others and there is no way of knowing before hand for sure what might work on a particular individual. Basically it's a trial and error situation.
